share_log

One Bio Secures $27 Million in Series A Funding to Revolutionize Nutrition With Launch of Breakthrough Technology Making High-Dose, Anti-Inflammatory Plant Fiber Imperceptible in Food and Beverage for the First Time

One Bio Secures $27 Million in Series A Funding to Revolutionize Nutrition With Launch of Breakthrough Technology Making High-Dose, Anti-Inflammatory Plant Fiber Imperceptible in Food and Beverage for the First Time

One Bio获得2700万美元A轮融资,革命性地推出突破性科技,使高剂量抗炎植物纤维首次在食品和饮料中变得不可察觉。
PR Newswire ·  12/14 04:28

New funding goes to groundbreaking products that pour plant fibers into our favorite foods to reduce the toxic impact of sugar and lower the incidence of metabolic disorders linked to the modern processed diet

新的资金用于开创性的产品,这些产品将植物纤维注入我们最喜欢的食物中,以减少糖的毒性影响并降低与现代加工饮食相关的代谢障碍的发病率

SACRAMENTO, Calif., Dec. 13, 2024 /PRNewswire/ -- One Bio, a pioneering biotechnology company committed to revolutionizing nutrition to empower people to live better, longer, has raised $27 million in Series A funding led by Alpha Edison and joined by new investors including Leaps by Bayer, Mitsui E12, Morado, ReMY, DSM-Ferminich, and Better – alongside existing investors including iSelect, Skyview Life Sciences, Collaborative and Acre. This catalytic investment round energized a unique global mix of strategic and institutional investors and is a testament to investor belief in One Bio's potential to reshape how much (and how often) the world consumes fiber, and to combat the disease epidemic linked to the modern processed diet by transforming your favorite foods into engines of good health while helping all of us reduce and eliminate the harm of sugar.

加利福尼亚州萨克拉门托,2024 年 12 月 13 日 /PRNewswire/-- One Bio是一家致力于彻底改变营养以使人们生活得更好、更长久的开创性生物技术公司,已通过阿尔法·爱迪生牵头的A轮融资筹集了2700万美元,包括拜耳Leaps、三井E12、Morado、reMy、dsm-Ferminich和Better在内的现有投资者以及包括iSelect、Skyview Life Sciences、Collaborative和Acre在内的现有投资者也加入了行列。本轮催化剂投资激发了独特的全球战略和机构投资者组合的活力,也证明了投资者对One Bio重塑世界纤维消耗量(和频率)的潜力,通过将你最喜欢的食物转化为健康的引擎,同时帮助我们所有人减少和消除糖的危害,来对抗与现代加工饮食相关的疾病疫情。

One Bio has innovated a technological process that releases anti-inflammatory short chain fibers from thousands of plants, making them undetectable, more bioactive and uniquely high dose. This novel process unlocks fibers from seeds, nuts, fruits, vegetables, legumes and grains.

One Bio创新了一种技术工艺,可从数千种植物中释放抗炎短链纤维,使其无法检测,更具生物活性,并且具有独特的高剂量。这种新颖的工艺可以从种子、坚果、水果、蔬菜、豆类和谷物中解锁纤维。

People today consume 10X more sugar than they did 200 years ago and 90% less fiber than we evolved to. Consequently, 95% of people are running a dramatic fiber deficiency that starves the microbiome while denying our bodies of core functions for healthspan. The result is skyrocketing rates of inflammatory disease including obesity, diabetes, cardiovascular, neurodegenerative, cancer and autoimmunity. One Bio promises a meaningfully positive shift in these alarming public health outcomes by not only eliminating traditional barriers to fiber consumption - like taste, texture, and appearance - but also reframing naturally-derived fiber as an essential but *undetectable* ingredient in our favorite foods and beverages.

如今,人们消耗的糖比200年前增加了10倍,纤维比我们进化到的水平减少了90%。因此,95% 的人患有严重的纤维缺乏,致使微生物组处于饥饿状态,同时剥夺了我们身体维持健康的核心功能。结果是包括肥胖、糖尿病、心血管、神经退行性、癌症和自身免疫在内的炎症性疾病的发病率飞涨。One Bio承诺将这些令人震惊的公共卫生结果发生有意义的积极转变,它不仅消除了传统的纤维消费壁垒(例如味道、质地和外观),而且还将天然衍生的纤维重新定义为我们最喜欢的食物和饮料中必不可少但*无法察觉*的成分。

As humans evolved, our beneficial gut microbes co-evolved to unlock and consume the sugars bound in the rich diversity of fibers present in plant foods to produce molecules we need to provide core functions including balancing our blood glucose, regulating mood & energy, and making us feel satiated. But modern diets composed of processed foods have isolated the sugars and discarded the fibers. One Bio short chain fibers can even provide an offramp to reduce the population's reliance on GLP-1s to treat chronic metabolic diseases: increasing consumption of high-fiber foods can prevent such diseases in the first place.

随着人类的进化,我们的有益肠道微生物共同进化,可以释放和消耗植物性食物中存在的丰富纤维中结合的糖,从而产生我们需要提供核心功能的分子,包括平衡血糖、调节情绪和能量以及使我们感到饱足。但是由加工食品组成的现代饮食已经分离出糖分并丢弃了纤维。One Bio短链纤维甚至可以为减少人们对GLP-1治疗慢性代谢疾病的依赖提供一个出路:增加高纤维食物的摄入量首先可以预防此类疾病。

"Modern food processing techniques strip plant fibers from our foods and starve the microbiome of the nutrients it needs to make us healthy. One Bio works to help us restore core functionality to our diet like blood glucose regulation and mood & energy balance. We aim to avoid and reverse the negative impact of today's processed food diet which accounts for 70% of calories consumed. We have the opportunity to offer industry and people an exponentially better set of choices than those on shelves today," said Matt Barnard, Co-founder and CEO of One Bio. "One Bio puts thriving microbiomes to work delivering longevity, aiding digestion and providing the fuel we need to maximize health," he added.

“现代食品加工技术会从我们的食物中去除植物纤维,使微生物组缺乏维持我们健康所需的营养。One Bio可以帮助我们恢复饮食的核心功能,例如血糖调节以及情绪和能量平衡。我们的目标是避免和扭转当今加工食品饮食的负面影响,加工食品占消耗卡路里的70%。One Bio联合创始人兼首席执行官马特·巴纳德说,我们有机会为业界和人们提供比当今货架上好得多的选择。他补充说:“One Bio让蓬勃发展的微生物群落发挥作用,延长寿命,帮助消化,为我们提供最大限度地提高生命值所需的燃料。”

"Faced with endless shelves of processed and packaged foods, and surrounded by chronic diseases, consumers are rapidly awakening to the power of the gut microbiome. An avalanche of signals points to a large pool of latent demand. This is One Bio's market," added Nate Redmond of Alpha Edison. "One Bio enables their partners to deliver functional products that reshape global health and unlock growth. We are thrilled to be working with Matt and the talented, passionate leaders who are building a category leading platform company.

“面对层出不穷的加工和包装食品,再加上慢性病,消费者正在迅速意识到肠道微生物组的力量。大量的信号表明了大量的潜在需求。这是One Bio的市场,” Alpha Edison的内特·雷德蒙德补充说。“One Bio使他们的合作伙伴能够提供功能性产品,重塑全球健康并解锁增长。我们很高兴能与 Matt 以及正在建立类别领先平台公司的才华横溢、充满激情的领导者合作。

For more information about One Bio, please visit one.bio.

有关 One Bio 的更多信息,请访问 one.bio.

About One Bio:
One Bio is a biotechnology company returning healthspan to our diet by reintroducing active plant fibers to our food and reshaping how we approach health and nutrition in everyday products. Using their cutting-edge technology, One Bio has demonstrated its ability to solve malnutrition in the modern diet. The company specializes in releasing short chain fibers from plants, while making them easily consumable and highly effective to invigorate our microbiome and immune system. Through its innovative solutions and strategic partnerships, One Bio aims to eradicate inflammatory disease and help people thrive.

关于 One Bio:
One Bio 是一家生物技术公司,通过在食物中重新引入活性植物纤维,并重塑我们在日常用品中注重健康和营养的方式,使我们的饮食恢复健康。利用他们的尖端技术,One Bio已经证明了其解决现代饮食中营养不良问题的能力。该公司专门从植物中释放短链纤维,同时使它们易于食用,并且对振兴我们的微生物组和免疫系统非常有效。通过其创新的解决方案和战略伙伴关系,One Bio旨在根除炎症性疾病并帮助人们茁壮成长。

Press contact:
Original Strategies
Simone Hassan-Bey
[email protected]

新闻联系人:
原创策略
西蒙娜·哈桑贝
[电子邮件保护]

SOURCE One Bio

来源 One Bio

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

想在 PRNEWSWIRE.COM 上刊登贵公司的新闻吗?

440k+
440k+

Newsrooms &
新闻编辑室和

Influencers
有影响力的人
9k+
9k+

Digital Media
数字媒体

Outlets
网点
270k+
270k+

Journalists
记者

Opted In
选择加入
GET STARTED
开始吧
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发